Artikel

When worlds converge: How Most-Favored-Nation policy and International Reference Pricing reshape global market access interdependencies

  • Erika Wissinger

  • David Ringger, PHD

  • Casper Paardekooper

  • Diane Smith

This article was originally published on ISPOR

Global drug pricing decisions do not happen in isolation

This article explores how most favored nation policies and international reference pricing are reshaping global market access by linking pricing, reimbursement, and launch decisions across markets. It highlights why manufacturers need a more coordinated strategy to anticipate downstream effects on pricing, access, and commercialization. 

Click below to read the full article today.

Wir sind hier, um zu helfen

Setzen Sie sich noch heute mit unserem Team in Verbindung, um mehr darüber zu erfahren, wie Cencora die Zukunft des Gesundheitswesens mitgestaltet.

Verwandte Ressourcen

Webinar

The first Joint Clinical Assessment is here: What market access teams should learn now

Leitfaden

Der unentbehrliche Leitfaden für die Vermarktung von Arzneimitteln

Webinar

Das transformative Potenzial von KI in HEOR und Marktzugang